Choroidal Neovascularization Market

Choroidal neovascularization describes the growth of new blood vessels that originate from the choroid through a break in the Bruch membrane into the sub?retinal pigment epithelium (sub-RPE) or subretinal space.

Choroidal Neovascularization Market contains market size and forecasts of Choroidal Neovascularization in global, including the following market information:

Global Choroidal Neovascularization Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Choroidal Neovascularization Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Choroidal Neovascularization companies in 2021 (%)

The global Choroidal Neovascularization market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Intravenous Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Choroidal Neovascularization include Pfizer Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Regeneron Pharmaceuticals Inc., Bayer AG, QLT Inc., Sanwa Kagaku Kenkyusho Co. Ltd., Promedior Inc. and Bausch Health and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Wesurveyed the Choroidal Neovascularization manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Choroidal Neovascularization Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Choroidal Neovascularization Market Segment Percentages, by Type, 2021 (%)

Intravenous

Intravitreal

Global Choroidal Neovascularization Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Choroidal Neovascularization Market Segment Percentages, by Application, 2021 (%)

Extreme Myopia

Malignant Myopic Degeneration

Age-Related Developments

Global Choroidal Neovascularization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Choroidal Neovascularization Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Choroidal Neovascularization revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Choroidal Neovascularization revenues share in global market, 2021 (%)

Key companies Choroidal Neovascularization sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Choroidal Neovascularization sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer Inc.

F. Hoffmann-La Roche Ltd.

Novartis AG

Regeneron Pharmaceuticals Inc.

Bayer AG

QLT Inc.

Sanwa Kagaku Kenkyusho Co. Ltd.

Promedior Inc.

Bausch Health

Gilead Sciences Inc